BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18945308)

  • 1. Blistering skin disorders: an evidence-based update. Conference report.
    Alexandroff AB; Harman KE
    Br J Dermatol; 2009 Mar; 160(3):502-4. PubMed ID: 18945308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New immunomodulating drugs in autoimmune blistering diseases.
    Korman NJ
    Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urticaria: an evidence-based update. Conference report.
    Alexandroff AB; Harman KE
    Br J Dermatol; 2010 Aug; 163(2):275-8. PubMed ID: 20666769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blistering diseases in the mature patient.
    Lakoš Jukić I; Jerković Gulin S; Marinović B
    Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition and bullous diseases.
    Stoj V; Lu J
    Clin Dermatol; 2022; 40(2):156-165. PubMed ID: 34808244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.
    Jolles S
    Clin Exp Dermatol; 2001 Mar; 26(2):127-31. PubMed ID: 11298100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.
    Kim M; Borradori L; Murrell DF
    Drugs Aging; 2016 Oct; 33(10):711-723. PubMed ID: 27738963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blistering diseases.
    Scott JE; Ahmed AR
    Med Clin North Am; 1998 Nov; 82(6):1239-83. PubMed ID: 9889748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autoimmune bullous diseases.
    Wakelin SH; Black MM
    J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
    [No Abstract]   [Full Text] [Related]  

  • 11. An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult.
    Yamase A; Kono T; Ishii N; Hashimoto T; Saeki H
    Br J Dermatol; 2016 Oct; 175(4):790-3. PubMed ID: 26989994
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in refractory autoimmune bullous diseases.
    Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
    Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune blistering diseases in children.
    Lara-Corrales I; Pope E
    Semin Cutan Med Surg; 2010 Jun; 29(2):85-91. PubMed ID: 20579597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blistering disorders: diagnosis and treatment.
    Yeh SW; Ahmed B; Sami N; Razzaque Ahmed A
    Dermatol Ther; 2003; 16(3):214-23. PubMed ID: 14510878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoimmune bullous skin disorders].
    Hertl M; Niedermeier A; Borradori L
    Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and emerging therapies in the treatment of blistering diseases.
    Korman NJ
    Dermatol Clin; 2000 Jan; 18(1):127-37, ix-x. PubMed ID: 10626118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
    Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
    Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases].
    Kasperkiewicz M; Zillikens D
    Hautarzt; 2007 Feb; 58(2):115-6, 118-21. PubMed ID: 17237928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.